MARCENARO, EMANUELA
 Distribuzione geografica
Continente #
EU - Europa 20.660
AS - Asia 2.351
NA - Nord America 2.061
Continente sconosciuto - Info sul continente non disponibili 504
SA - Sud America 201
AF - Africa 36
OC - Oceania 3
Totale 25.816
Nazione #
IT - Italia 20.206
US - Stati Uniti d'America 1.919
SG - Singapore 913
CN - Cina 623
VN - Vietnam 387
BD - Bangladesh 203
FR - Francia 198
BR - Brasile 122
HK - Hong Kong 77
CA - Canada 68
FI - Finlandia 63
DE - Germania 47
GB - Regno Unito 42
JP - Giappone 39
AR - Argentina 33
CH - Svizzera 25
MX - Messico 23
NL - Olanda 16
EC - Ecuador 15
IQ - Iraq 15
PH - Filippine 14
TR - Turchia 13
IN - India 12
CR - Costa Rica 11
ID - Indonesia 10
ES - Italia 9
JM - Giamaica 8
PK - Pakistan 8
CL - Cile 7
ZA - Sudafrica 7
CO - Colombia 6
IE - Irlanda 6
KR - Corea 6
PE - Perù 6
RU - Federazione Russa 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
GT - Guatemala 5
MA - Marocco 5
NI - Nicaragua 5
BG - Bulgaria 4
BO - Bolivia 4
DZ - Algeria 4
NO - Norvegia 4
PR - Porto Rico 4
TN - Tunisia 4
UA - Ucraina 4
VE - Venezuela 4
AU - Australia 3
KE - Kenya 3
MY - Malesia 3
PL - Polonia 3
PT - Portogallo 3
PY - Paraguay 3
SE - Svezia 3
SV - El Salvador 3
UZ - Uzbekistan 3
AL - Albania 2
AT - Austria 2
BB - Barbados 2
BH - Bahrain 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ET - Etiopia 2
JO - Giordania 2
LT - Lituania 2
MD - Moldavia 2
MK - Macedonia 2
PS - Palestinian Territory 2
SA - Arabia Saudita 2
SC - Seychelles 2
SI - Slovenia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AI - Anguilla 1
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
HT - Haiti 1
IL - Israele 1
IR - Iran 1
LB - Libano 1
MT - Malta 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 25.308
Città #
Genova 11.514
Genoa 5.219
Rapallo 1.653
Vado Ligure 1.437
San Jose 562
Singapore 422
Ashburn 175
Lauterbourg 169
Beijing 126
Ho Chi Minh City 120
New York 106
Hanoi 88
Hong Kong 70
Milan 67
Council Bluffs 66
Santa Clara 64
Helsinki 59
Bordighera 51
Los Angeles 50
Frankfurt am Main 41
Rome 36
Tokyo 36
Dallas 25
Haiphong 22
Zurich 22
Buffalo 19
Da Nang 19
Chicago 18
Toronto 16
Mexico City 15
Orem 15
Atlanta 14
Montreal 14
Phoenix 14
Washington 14
Valenza 13
Figino 12
Tianjin 12
Catania 10
Des Moines 10
Houston 10
London 10
San José 10
Amsterdam 9
Boardman 9
Cardiff 9
City of London 9
Bologna 8
Guayaquil 8
Naples 8
São Paulo 8
Marseille 7
Shanghai 7
Turin 7
Baghdad 6
Charlotte 6
Dublin 6
Hải Dương 6
Istanbul 6
Louisville 6
Padua 6
Queens 6
The Bronx 6
Bangkok 5
Bari 5
Basingstoke 5
Biên Hòa 5
Brasília 5
Brooklyn 5
Can Tho 5
Columbus 5
Denver 5
Jacksonville 5
Las Vegas 5
Lawrenceville 5
Managua 5
Miami 5
Philadelphia 5
Piscataway 5
San Antonio 5
San Francisco 5
Asheville 4
Bắc Ninh 4
Calgary 4
Guatemala City 4
Johannesburg 4
Kingston 4
Manchester 4
Medellín 4
Messina 4
Minneapolis 4
Nashville 4
Ninh Bình 4
Paris 4
Pasadena 4
Porto Alegre 4
Providence 4
Santa Rosa 4
Stockton 4
Albuquerque 3
Totale 22.753
Nome #
Different features of tumor-associated NK cells in patients with low-grade or high-grade peritoneal carcinomatosis 256
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 236
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 223
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 221
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 220
2B4 functions as a co-receptor in human NK cell activation 216
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 208
NK/DC crosstalk in anti-viral response. 207
Bridging innate NK cell Functions with Adaptive Immunity. 206
Features of Memory-Like and PD-1+ Human NK Cell Subsets 205
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 205
Feasibility and Efficacy of Post-Transplant Consolidation Immunotherapy with Nivolumab Supported By the Reinfusion of Unselected Autologous Lymphocytes in Patients Affected By Relapsed/Refractory Hodgkin Lymphoma 200
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells. 197
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 193
Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. 192
An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More 190
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 188
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway 187
Markers and function of human NK cells in normal and pathological conditions 186
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 185
PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression 185
NK cells and their receptors during viral infections. 183
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 183
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 180
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 180
Harnessing NK Cells for Cancer Treatment 178
Multi-directional cross-regulation of NK cell function during innate immune responses. 176
Human NK cell response to pathogens 173
Predictors of poor seroconversion and adverse events to SARS-CoV-2 mRNA BNT162b2 vaccine in cancer patients on active treatment 173
The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer cells represents a therapeutic target in haploidentical haematopoietic stem cell transplantation 172
CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AML 170
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 169
Adoptive Cell Therapy and Immune Check Points Inhibitors As a Salvage Treatment for Patient Affected By Relapsed/Refractory Hodgkin's Lymphoma 169
Role of the 2B4 receptor in CD8+ T-cell-dependent immune control of Epstein-Barr virus infection in mice with reconstituted human immune system components 168
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 168
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 167
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 161
Natural killer lymphocytes: "null cells" no more. 161
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 158
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 157
Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1β, IFN-β, and IL-15 Pathways 157
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 155
PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells 155
NK Cell-Based Immunotherapy in Colorectal Cancer 154
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells 154
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 154
Cancer immunotherapy by blocking immune checkpoints on innate lymphocytes 154
It's only innate immunity but I like it 153
Lysis of endogenously infected CD4+ T cell blasts by rIL-2 activated autologous natural killer cells from HIV-infected viremic individuals. 152
Pathogen-induced private conversations between natural killer and dendritic cells 152
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 152
Early liaisons between cells of the innate immune system in inflamed peripheral tissues 152
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells 150
Human NK Cells Induce Neutrophil Apoptosis via an NKp46- and Fas-Dependent Mechanism. 150
Targeting NKG2A to elucidate natural killer cell ontogenesis and to develop novel immune-therapeutic strategies in cancer therapy 149
Natural killer cell-triggering receptors in patients with acute leukaemia. 148
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 148
PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua 148
miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy 148
New miRNA signature heralds human NK cell subsets at different maturation steps: involvement of miR- 146a-5p in the regulation of KIR expression 147
Downregulation of HLA Class I Renders Inflammatory Neutrophils More Susceptible to NK Cell-Induced Apoptosis 147
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues 146
Unraveling the regulatory role of NK cells on T-cell effector functions: Implications for CNS autoimmunity 146
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 146
CD94 functions as a natural killer cell inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 146
Adaptor protein 3 complex deficiency causes innate immunity defects 144
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 144
New Insights into Endometrial Cancer 144
TLR/NCR/KIR: Which One to Use and When? 143
Identification of NKG2A and NKp80 as specific Natural Killer cell markers in rhesus and pigtailed monkeys 143
NK cell receptors in anti-tumor and healthy tissue protection: Mechanisms and therapeutic advances 142
Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. 142
IL-12 or IL-4 prime human Natural Killer cells to mediate functionally divergent interactions with Dendritic cells or tumors 142
Primitive Neuroectodermal Tumor in an Ovarian Cystic Teratoma: Natural Killer and Neuroblastoma Cell Analysis 142
IL-12 or IL-4 prime human Natural Killer Cells to mediate functionally diverent interactions with dendritic cells or tumors 142
IL-12 or IL-4 prime human natural killer cells to mediate functionally divergent interactions with dendritic cells or tumors 141
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands 141
IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors 140
Human NK cells directly recognize Mycobacterium Bovis and acquire the ability to interact with monocyte-derived DC 139
Regulatory Functions of Natural Killer Cells in Multiple Sclerosis 139
Role of alloreactive KIR2DS1+ NK cells in haploidentical hematopoietic stem cell transplantation. 139
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis 138
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 137
Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. 136
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. 136
The landscape of combining immune checkpoint inhibitors with novel Therapies: Secret alliances against breast cancer 135
Natural killer cells in HIV-Infectious: Dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates. 134
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 133
Human NK cells directly recognize Mycobacterium bovis and acquire the ability to interact with monocyte-derived DC 133
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer 132
Harnessing Immune Response in Acute Myeloid Leukemia 131
Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia 131
The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer cell subsets associated with high levels of HIV-1 viremia. 130
Cognate HLA absence in trans diminishes human NK cell education 130
NK cells: innate immunity against hematological malignancies? 130
Role of the main non HLA-specific activating NK receptors in pancreatic, colorectal and gastric tumors surveillance 130
Editorial: NK Cell Subsets in Health and Disease: New Developments 129
Human Natural Killer cells expressing high levels of Natural Citotoxicity Receptors (NCR) directly respond to Mycobacterium Bovis Bacillus Calmette-Guerin 129
The NK/DC complot 128
Comprehensive Phenotyping of Human PB NK Cells by Flow Cytometry 128
Totale 16.092
Categoria #
all - tutte 83.310
article - articoli 64.677
book - libri 720
conference - conferenze 9.314
curatela - curatele 0
other - altro 528
patent - brevetti 5.529
selected - selezionate 0
volume - volumi 2.542
Totale 166.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.122 77 160 151 183 116 118 142 495 156 186 95 243
2022/20232.047 238 154 23 194 297 348 4 178 381 21 178 31
2023/20241.164 63 177 34 136 93 122 80 125 69 48 80 137
2024/20253.516 76 260 133 229 511 337 363 501 117 191 375 423
2025/20266.369 706 177 420 479 766 603 960 298 464 632 378 486
2026/2027774 774 0 0 0 0 0 0 0 0 0 0 0
Totale 25.816